Siemens extends Impac rad onc deal

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Siemens Healthcare is expanding its portfolio for cancer therapy by partnering with Impac Medical Systems, which includes an extension of its software distribution agreement to 2016 and adding the Mosaiq software to its oncology portfolio.

The partnership with Impac, an Elekta company, will allow Siemens customers access to Impac's oncology information system (OIS) as well as Siemens' radiation therapy systems. Siemens and the Sunnyvale, Calif.-based Impac also will work together to develop interfaces between Mosaiq and Intris, with the intent to use Mosaiq with Siemens particle therapy solutions.

Under the extended agreement, Siemens will offer the Mosaiq software as its next generation OIS offering to Lantis users, which is Siemens' current OIS product. Siemens said its Lantis customers will have the option of upgrading to Mosaiq or continuing to utilize their Lantis systems. Siemens will extend service support and application training for its customers to include Mosaiq.